Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma
Background and Purpose:
Oxygen-enhanced magnetic resonance imaging (MRI) and T1-mapping was used to explore its effectiveness as a prognostic imaging biomarker for chemoradiotherapy outcome in anal squamous cell carcinoma.
Materials and Methods:Expand abstract
T2-weighted, T1 mapping, and oxygen-enhanced T1 maps were acquired before and after 8–10 fractions of chemoradiotherapy and examined whether the oxygen-enhanced MRI response relates to cli...
- Publication status:
- Peer review status:
- Peer reviewed
(Version of record, 1.3MB)
- Publisher copy:
- Copyright holder:
- Bluemke et al.
- Copyright date:
- Rights statement:
- © 2020 Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology. This is an open access article under the CC BY license.
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record